Geoffrey Francis, Chief Scientist at Novozymes Biopharma, has been named one of the 100 most inspiring people by PharmaVOICE magazine in recognition of his influence on the life sciences industry.
The PharmaVOICE 100 were nominated by PharmaVoice readers, who identified the individuals they believe have the greatest influence and positive impact on corporate leadership, research and development, technology, creativity, marketing and business strategies.
“It’s a great honor to have been recognised by my peers and to be profiled alongside such an esteemed group of industry leaders,” commented Geoffrey Francis. “I am delighted that this honor validates Novozymes Biopharma’s mission and is a real testament to the outstanding team we have here.”
Geoffrey Francis’ nomination and selection to the PharmaVOICE 100 was based on his exceptional 30-year career in the life sciences and biotechnology industries and his ability to inspire and motivate those around him.
With specific expertise in drug discovery, protein expression, cell biology, animal physiology and protein biochemistry, Geoffrey has a long and successful career in senior management and research within government, academia and industry.
Geoffrey used his expertise as part of the team to found the Cooperative Research Centre for Tissue Growth and Repair, Adelaide in 1991 and held senior scientist positions at CSIRO Human Nutrition and GroPep Ltd before joining Novozymes Biopharma in 2006.
Editor-in-chief and co-founder of PharmaVOICE Taren Grom said: “The PharmaVoice 100 are individuals who think outside the box, pioneer new paths to success, and inspire their colleagues in the industry; they translate industry issues into opportunities and take the time to mentor the next generation of leaders in the life sciences arena.”